Cargando…

THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab

Disclosure: I. Iqbal: None. M. Khan: None. M. Ahmad: None. R. Mehreen: None. Introduction: Pembrolizumab is a programmed cell death receptor (PD-1) binder on T cells, which promotes their activation against cancer cells. It can also cause unwanted T cell activation against the body’s own cells, lead...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iqbal, Iqra, Alam Khan, Muhammad Atique, Ahmad, Mobeen, Mehreen, Rameesha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553469/ http://dx.doi.org/10.1210/jendso/bvad114.807

Ejemplares similares

THU383 “My Hands Are Always Stiff”: A Common But Underrecognized Mimicker Of Inflammatory Arthritis.
por: Iqbal, Iqra, et al.
Publicado: (2023)

THU376 Isotretinoin Related DKA In Type 2 Diabetes
por: Radovanovic, Natasa, et al.
Publicado: (2023)

THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor
por: Ahmed, Samihah, et al.
Publicado: (2023)

THU247 Characterizing Inpatient Cases Of DKA Precipitated By SGLT2 Inhibitor Use
por: Aslamy, Arianne, et al.
Publicado: (2023)

THU291 Successful Reversal Of Glucose Toxicity After DKA Precipitated By SGLT2 Inhibitor
por: Abdelrahman, Houda, et al.
Publicado: (2023)

THU379 A Case Of Hyperglycemia With Severe Anion Gap Metabolic Acidosis: HHS Vs DKA
por: Shrivastava, Mashu, et al.
Publicado: (2023)

THU380 A Case Of Alpelisib Induced Diabetic Ketoacidosis (Dka) In A Patient With Type 2 Diabetes Mellitus And Rechallenge With SGLT2 Inhibitor
por: Sekar, Vijaykumar, et al.
Publicado: (2023)

SAT-676 Pembrolizumab Induced Worsening Glycemic Control and DKA in Type 2 Diabetes Mellitus
por: Goud, Sarita, et al.
Publicado: (2020)

THU316 Relatively Rare And Increasingly Fatal; A Case Of Euglycemic DKA In A Patient With Gestational Diabetes
por: Dimech, Christina, et al.
Publicado: (2023)

LBSUN292 Learning Lesson From A Case of Fulminant Type 1 Diabetes Mellitus Shortly After Pembrolizumab Treatment
por: Phan, Van, et al.
Publicado: (2022)

ODP165 Atypical DKA? Think Cannabis!
por: Albashaireh, Arwa, et al.
Publicado: (2022)

THU361 Diabetic Ketoacidosis As The Initial Presentation Of Pancreatic Adenocarcinoma, A Case Report
por: Siddiqui, Usman, et al.
Publicado: (2023)

PSUN240 A Case of Euglycemic DKA in Pregnancy
por: Grigoryan, Seda, et al.
Publicado: (2022)

SAT036 Chlorthalidone Implicated In The Development Of DKA HHS Overlap In A Patient With Type II Diabetes Mellitus
por: Hilder, Robin T
Publicado: (2023)

THU378 Presentation Of Autoimmune Destruction Of Pancreatic Beta Cells By Pembrolizumab In The Setting Of Existing Type 2 Diabetes
por: Seidenberg, Jacob, et al.
Publicado: (2023)

LBSAT236 A Case of Immune Checkpoint Inhibitor Pembrolizumab Induced Simultaneous Rare Endocrinopathies, Type 1 DM (presenting As DKA) And Grave's Thyrotoxicosis, With Evidence Of Autoimmunity Development.
por: Arora, Gunjan, et al.
Publicado: (2022)

SAT058 Diabetes Complicated By DKA, Mucormycosis And Covid-19
por: Gordon, Ashley
Publicado: (2023)

PSUN251 Euglycemic DKA In A Patient Undergoing Major Surgery
por: Dapas, Natalie, et al.
Publicado: (2022)

Role of Bariatric Surgery in Managing Metabolic Syndrome
por: Iqbal, Iqra, et al.
Publicado: (2021)

PSAT035 COVID-19 Infection Increases DKA and mortality- A Harbinger for Increased Acute Diabetes Emergencies in the Future?
por: Firek, Anthony, et al.
Publicado: (2022)

THU342 Per And Polyfluoroalkyl Substances And Prevalence Of Diabetes Mellitus In Korean Adults
por: Kim, Shin-Hye
Publicado: (2023)

ODP244 SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges
por: Penna, Laurianne El Musa, et al.
Publicado: (2022)

ODP628 Quality Improvement Project (QIP) On Management Of Diabetic Ketoacidosis (DKA) In Adults In A District General Hospital.
por: Haddad, Aiman, et al.
Publicado: (2022)

THU317 Study Of Risk Factors For The Development Of Various Subtypes Of Gestational Diabetes Mellitus
por: Volkova, Natalia I, et al.
Publicado: (2023)

THU363 Misdiagnosing Latent Autoimmune Diabetes Mellitus In Adults: A Case Report
por: Rafat, Ummara, et al.
Publicado: (2023)

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management
por: Al-Marsumi, Hadeel, et al.
Publicado: (2023)

SUN-178 A Not So "Sweet" DKA: A Case of Euglycemic Diabetic Ketoacidosis Caused by Dapagliflozin/Liraglutide Combination
por: Sideri Gugger, Aristea, et al.
Publicado: (2019)

SAT-LB112 An Unusual Case of Ipilimumab/Nivolumab Induced Fulminant Diabetic Ketoacidosis (DKA) in a Non Diabetic Patient - a Case Report
por: Abdelmasih, Randa, et al.
Publicado: (2020)

THU289 Hemichorea-Hemiballismus Syndrome Secondary To Steroid Induced Hyperglycemia In A Nondiabetic
por: Krishnaraju, Ellil, et al.
Publicado: (2023)

THU307 Landscapes Of MaternalAnd Neonatal Bacterial And Metabolic SignaturesAnd Their Interaction In Gestational Diabetes Mellitus
por: Ding, Lu, et al.
Publicado: (2023)

THU248 Screening For Heart Failure In Patients With Diabetes Mellitus - A SwissDiab Study
por: Brandle, Michael, et al.
Publicado: (2023)

LBODP057 Association Between DKA And Live Abscess: Results From The National Inpatient Sample
por: Muammar, Ahmad, et al.
Publicado: (2022)

Selecting Patients at Risk of Developing DKA on Gliflozins
por: Maletkovic, Jelena
Publicado: (2021)

Euglycemic DKA Associated With SGLT2 Inhibitors
por: TakallooBakhtiari, Asieh, et al.
Publicado: (2021)

THU369 A Rare Case Of IgG4-related Autoimmune Pancreatitis And Diabetes Mellitus
por: Zahid, Maleeha, et al.
Publicado: (2023)

ODP230 Outcomes of DKA Based on Hospital Teaching Status: A National Inpatient Sample Analysis
por: Ramirez, Marcelo, et al.
Publicado: (2022)

THU384 Too Sweet To Digest; A Case Of Persistent Lactic Acidosis Secondary To Glycogenic Hepatopathy
por: Ayub, Tooba, et al.
Publicado: (2023)

THU273 Sixteen Years Of Insulin Independence In A Patient With Type 1 Diabetes Mellitus Following Single-Donor Islet Cell Transplantation
por: Kachhadia, Palak, et al.
Publicado: (2023)

Precipitation of Euglycemic DKA (euDKA) From the Initiation of SGLT2 Inhibitor (SGLT2i) and 0-Carb Diet Inpatient
por: Popli, Rakesh, et al.
Publicado: (2021)

THU327 Characterization Of New Onset Diabetes Mellitus Concurrent With COVID-19; A Single Institution Experience
por: Haque, Tania, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_61n3m4e27ksqcibe0sh4k54sov